Entitlement offer Announced
Percheron Therapeutics entitlement offer
A$2.2m raised
Announced 16 Mar 2026 · A$0.005 cash per share
Advisers
Lead managers
- Joint lead manager
- Issuer
- Percheron Therapeutics
- Structure
- Traditional non-renounceable entitlement offer
- Sector
- Biotech and pharmaceuticals
Similar deals
- AdAlta placement May 2026 · A$2.5m · Biotech and pharmaceuticals
- Biotron placement Oct 2025 · A$2.5m · Biotech and pharmaceuticals
- AGH placement Sep 2025 · A$2.5m · Biotech and pharmaceuticals
- Bioxyne placement Mar 2025 · A$3m · Biotech and pharmaceuticals
- Xenitra placement Aug 2026 · A$1.5m · Biotech and pharmaceuticals
Sources
- 16 Mar 2026 Prospectus - Non-renounceable Entitlement Offer ASX